Hi everyone,

I would like to ask if it is necessary to validate the control test (eg sub-visible particles) for each Finished Pharmaceutical Product (FPP) separately (using the same method, the same equipment, environment ...) or can it be based on the validation of the control test method (which does not change in various FPP) ?

Could I find anything about this anywhere in the guidelines?

Thank you very much.

Similar questions and discussions